Hepatitis C virus and human miR-122: insights from the bench to the clinic.

MicroRNAs (miRNAs) are small non-coding RNAs that function as part of RNA-induced silencing complexes that repress the expression of target genes. Over the past few years, miRNAs have been found to mediate complex regulation of a wide variety of mammalian viral infections, including Hepatitis C virus (HCV) infection. Here, we focus on a highly abundant, liver-specific miRNA, miR-122. In a unique and unusual interaction, miR-122 binds to two sites in the 5' untranslated region (UTR) of the HCV genome and promotes viral RNA accumulation. We will discuss what has been learned about this important interaction to date, provide insights into how miR-122 is able to modulate HCV RNA accumulation, and how miR-122 might be exploited for antiviral intervention.

[1]  K. Kodys,et al.  Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor α (TNFα) Production via Increased mRNA Half-life in Alcoholic Liver Disease* , 2010, The Journal of Biological Chemistry.

[2]  S. Seong,et al.  Transcriptional Regulation of IFN-λ Genes in Hepatitis C Virus-infected Hepatocytes via IRF-3·IRF-7·NF-κB Complex* , 2014, The Journal of Biological Chemistry.

[3]  W. Kamitani,et al.  Establishment of a Novel Permissive Cell Line for the Propagation of Hepatitis C Virus by Expression of MicroRNA miR122 , 2011, Journal of Virology.

[4]  Thomas Berg,et al.  IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.

[5]  W. Chapman,et al.  Hepatitis C Virus Mediated Changes in miRNA-449a Modulates Inflammatory Biomarker YKL40 through Components of the NOTCH Signaling Pathway , 2012, PloS one.

[6]  S. Lemon,et al.  Stabilization of hepatitis C virus RNA by an Ago2–miR-122 complex , 2012, Proceedings of the National Academy of Sciences.

[7]  A. Koike,et al.  Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.

[8]  X. Bian,et al.  The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 , 2011, Gut.

[9]  P. Zamore,et al.  Kinetic analysis of the RNAi enzyme complex , 2004, Nature Structural &Molecular Biology.

[10]  Michael Niepmann,et al.  microRNA-122 stimulates translation of hepatitis C virus RNA , 2008, The EMBO journal.

[11]  G. Meister,et al.  microRNA-122 Dependent Binding of Ago2 Protein to Hepatitis C Virus RNA Is Associated with Enhanced RNA Stability and Translation Stimulation , 2013, PloS one.

[12]  Ding‐Shinn Chen,et al.  Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C , 2013, Proceedings of the National Academy of Sciences.

[13]  C. Croce,et al.  MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma , 2008, Oncogene.

[14]  D. Tyrrell,et al.  The Second Canadian Symposium on hepatitis C virus: a call to action. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[15]  N. Hayashi,et al.  Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway. , 2011, Biochemical and biophysical research communications.

[16]  P. Su,et al.  Identification of a Novel Antimicrobial Peptide from Human Hepatitis B Virus Core Protein Arginine-Rich Domain (ARD) , 2013, PLoS pathogens.

[17]  Sara R. Selitsky,et al.  microRNA-122 Abundance in Hepatocellular Carcinoma and Non-Tumor Liver Tissue from Japanese Patients with Persistent HCV versus HBV Infection , 2013, PloS one.

[18]  P. Sarnow,et al.  Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex , 2011, Proceedings of the National Academy of Sciences.

[19]  J. Qian,et al.  MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1. , 2013, The international journal of biochemistry & cell biology.

[20]  K. Norman,et al.  Modulation of Hepatitis C Virus RNA Abundance and the Isoprenoid Biosynthesis Pathway by MicroRNA miR-122 Involves Distinct Mechanisms , 2009, Journal of Virology.

[21]  M. Odenthal,et al.  Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. , 2013, Journal of hepatology.

[22]  Joyce A. Wilson,et al.  miR‐122 Promotion of the hepatitis C virus life cycle: sound in the silence , 2013, Wiley interdisciplinary reviews. RNA.

[23]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[24]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[25]  Sam Griffiths-Jones,et al.  The microRNA Registry , 2004, Nucleic Acids Res..

[26]  C. Rice,et al.  Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses , 2013, mBio.

[27]  R. Bartenschlager,et al.  Role of RNA Structures in Genome Terminal Sequences of the Hepatitis C Virus for Replication and Assembly , 2009, Journal of Virology.

[28]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[29]  H. Bonkovsky,et al.  MicroRNA‐196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins , 2010, Hepatology.

[30]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[31]  M. Fassan,et al.  MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis , 2014, Journal of gastroenterology and hepatology.

[32]  Hsien-Da Huang,et al.  Let-7b is a novel regulator of hepatitis C virus replication , 2012, Cellular and Molecular Life Sciences.

[33]  M. Caligiuri,et al.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. , 2012, The Journal of clinical investigation.

[34]  Joyce A. Wilson,et al.  MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells. , 2013, Virology.

[35]  L. Laan,et al.  Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte‐derived microRNA‐122 , 2013, Journal of viral hepatitis.

[36]  Rodney Russell,et al.  MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-α , 2013, PloS one.

[37]  C. Richardson,et al.  Human Ago2 Is Required for Efficient MicroRNA 122 Regulation of Hepatitis C Virus RNA Accumulation and Translation , 2010, Journal of Virology.

[38]  Ligang Wu,et al.  MicroRNAs direct rapid deadenylation of mRNA. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Imamura,et al.  Genetics of IL28B and HCV—response to infection and treatment , 2012, Nature Reviews Gastroenterology &Hepatology.

[40]  K. Yoshizato,et al.  MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis , 2012, Gut.

[41]  Takaji Wakita,et al.  Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. , 2010, Virology.

[42]  J. Doudna,et al.  Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure , 2013, Nucleic acids research.

[43]  W. Fendler,et al.  Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells. , 2011, International journal of molecular medicine.

[44]  A. García-Sastre,et al.  miR-122 is more than a shield for the hepatitis C virus genome , 2013, Proceedings of the National Academy of Sciences.

[45]  Saumitra Das,et al.  Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis , 2013, Scientific Reports.

[46]  Yoshiki Murakami,et al.  Regulation of the hepatitis C virus genome replication by miR-199a. , 2009, Journal of hepatology.

[47]  B. Liu,et al.  MicroRNA‐130a inhibits HCV replication by restoring the innate immune response , 2014, Journal of viral hepatitis.

[48]  H. Dienes,et al.  Kinetics of miR-122 Expression in the Liver during Acute HCV Infection , 2013, PloS one.

[49]  G. Superti-Furga,et al.  IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA , 2011, Nature Immunology.

[50]  Angela M. Liu,et al.  Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122* , 2011, The Journal of Biological Chemistry.

[51]  Stefano Volinia,et al.  Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.

[52]  C. Rice,et al.  Characterization of a canine homolog of hepatitis C virus , 2011, Proceedings of the National Academy of Sciences.

[53]  Benjamin Israelow,et al.  HepG2 Cells Expressing MicroRNA miR-122 Support the Entire Hepatitis C Virus Life Cycle , 2011, Journal of Virology.

[54]  Anton P. McCaffrey,et al.  Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans , 2010, Laboratory Investigation.

[55]  Anton P. McCaffrey,et al.  Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. , 2011, The Journal of infectious diseases.

[56]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[57]  Eva Herrmann,et al.  Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection , 2011, The American Journal of Gastroenterology.

[58]  R. Lanford,et al.  Lack of response to exogenous interferon‐α in the liver of chimpanzees chronically infected with hepatitis C virus , 2007, Hepatology.

[59]  P. Simmonds The origin of hepatitis C virus. , 2013, Current topics in microbiology and immunology.

[60]  Hsien-Da Huang,et al.  MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma , 2009, Hepatology.

[61]  Jacques Fellay,et al.  IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C , 2010, Hepatology.

[62]  Changfei Li,et al.  Inhibition of Alpha Interferon (IFN-α)-Induced MicroRNA-122 Negatively Affects the Anti-Hepatitis B Virus Efficiency of IFN-α , 2012, Journal of Virology.

[63]  M. Honda,et al.  Hepatic interferon‐stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin‐28B genotypes , 2014, Hepatology.

[64]  Rodney K. Lyn,et al.  Hepatitis C virus induced up‐regulation of microRNA‐27: A novel mechanism for hepatic steatosis , 2014, Hepatology.

[65]  M. Cam,et al.  Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response , 2007, Hepatology.

[66]  Hsien-Da Huang,et al.  MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. , 2012, The Journal of clinical investigation.

[67]  F. Luo,et al.  MiR‐29 mediates TGFβ1‐induced extracellular matrix synthesis through activation of PI3K‐AKT pathway in human lung fibroblasts , 2013, Journal of cellular biochemistry.

[68]  Quanbo Zhou,et al.  Epigenetic regulation of miR‐124 by Hepatitis C Virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3 , 2012, FEBS letters.

[69]  Limin Chen,et al.  Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. , 2005, Gastroenterology.

[70]  S. Lemon,et al.  Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replication , 2012, Proceedings of the National Academy of Sciences.

[71]  Yoshiki Murakami,et al.  The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families , 2011, PloS one.

[72]  Andrew P Lewis,et al.  Regulation and biological function of the liver-specific miR-122. , 2010, Biochemical Society transactions.

[73]  Catherine L Jopling,et al.  Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. , 2008, Cell host & microbe.

[74]  T. Asselah,et al.  Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C , 2007, Gut.

[75]  W. Filipowicz,et al.  Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy , 2009, Nature Medicine.

[76]  M. Honda,et al.  MicroRNA-27a Regulates Lipid Metabolism and Inhibits Hepatitis C Virus Replication in Human Hepatoma Cells , 2013, Journal of Virology.

[77]  C. Scagnolari,et al.  Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha , 2010, Virology Journal.

[78]  Liang-Tzung Lin,et al.  Replication of Subgenomic Hepatitis C Virus Replicons in Mouse Fibroblasts Is Facilitated by Deletion of Interferon Regulatory Factor 3 and Expression of Liver-Specific MicroRNA 122 , 2010, Journal of Virology.

[79]  Yiliang Zhang,et al.  Hepatitis C virus‐induced up‐regulation of microRNA‐155 promotes hepatocarcinogenesis by activating Wnt signaling , 2012, Hepatology.

[80]  S. Lowe,et al.  miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.

[81]  D. Tyrrell,et al.  Hepatitis C virus and microRNAs: miRed in a host of possibilities. , 2014, Current opinion in virology.

[82]  Joyce A. Wilson,et al.  Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host. , 2013, Pharmacological research.

[83]  S. Kauppinen,et al.  Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.

[84]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[85]  P. Sarnow,et al.  Modulation of GB Virus B RNA Abundance by MicroRNA-122: Dependence on and Escape from MicroRNA-122 Restriction , 2013, Journal of Virology.

[86]  K. Horimoto,et al.  Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma , 2009, Hepatology.

[87]  O. Pellegrini,et al.  In vitro assays of 5' to 3'-exoribonuclease activity. , 2008, Methods in enzymology.

[88]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[89]  B. Kronenberger,et al.  Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[90]  S. Lemon,et al.  miR-122 and the Hepatitis C RNA genome , 2013, RNA biology.